Demonstration of regional sympathetic denervation of the heart in diabetes: Comparison between patients NIDDM and IDDM

Diabetes Care

Volumn 19, Issue 10, 1996, Pages 1083-1090

  Turpeinen, Anu K ^a,b   Kuikka, Jyrki T ^a   Vanninen, Esko ^a   Uusitupa, Matti I J ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; ECHOCARDIOGRAPHY; FEMALE; HEART DENERVATION; HEART INNERVATION; HEART MUSCLE PERFUSION; HEART RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTRAVENOUS DRUG ADMINISTRATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPATHETIC INNERVATION;

EID: 10144230009     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.10.1083     Document Type: Article

References (35)

1. Fagret D, Wolf J-E, Vanzetto G, Borrel E: Myocardial uptake of metaiodobenzylguanidine with left ventricular hypertrophy secondary to valvular aortic stenosis. J Nucl Med 34:57-60, 1993
2. Dae MW, De Marco T, Botvinick EH, O'Connell JW, Hattner RS, Huberty JP, Yuen-Green MS: Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts - implications for clinical studies. J Nucl Med 33:1444-1450, 1992
3. Kline RC, Swanson DP, Wieland DM, Thrall JH, Gross MD, Pitt B, Beierwaltes WH: Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med 22:119-132, 1981
4. 123I-metaiodobenzylguanidine. Diabetes 41:1069-1075, 1992
5. Langer A, Freeman MR, Josse RG, Amstrong PW: Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia. J Am Coll Cardiol 25:610-618, 1995
6. 123I]Iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM. Diabetes 44:543-549, 1995
7. Khafagi FA, Shapiro B, Fig LM, Mallette S, Sisson JC: Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues. J Nucl Med 30:481-489, 1989
8. Hartikainen J, Tarkiainen I, Tahvanainen K, Mäntysaari M, Länsimies E, Pyörälä K: Circadian variation of cardiac autonomic regulation during 24-hour bed rest. Clin Physiol 3:185-196, 1993
9. Tahvanainen K, Länsimies E, Tikkanen P, Hartikainen J, Kärki T, Lyyra T, Mäntysaari M: Microcomputer-based monitoring of cardiovascular functions in simulated microgravity. Adv Space Res 12:227-236, 1992
10. Armstrong FM, Bradbury J, Ellis SH, Owens DR, Rosen I, Sonksen P, Sundkvist G: A study of peripheral diabetic neuropathy: the application of age-related reference values. Diabetic Med 8:s94-s99, 1991
11. Farrell TG, Paul V, Cripps TR, Malik M, Bennett ED, Ward D, Camm AJ: Baroreflex sensitivity and electrophysiological correlates in patients after acute myocardial infarction. Circulation 83:945-952, 1991
12. Piha SJ: Cardiovascular Autonomic Function Tests. Turku, Finland, Social Insurance Institution, 1988
13. Vanninen E, Mustonen J, Vainio P, Länsimies E, Uusitupa M: Left ventricular function and dimensions in newly diagnosed non-insulin-dependent diabetes mellitus. Am J Cardiol 70:371-378, 1992
14. Sahn DJ, DeMaria A, Kisslo J, Weyman A: Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurement. Circulation 58:1072-1083, 1978
15. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 55:613-018, 1977
16. Nyyssönen K, Parviainen MT: Practical observations and sources of error in assays of plasma catecholamines by "high performance" liquid chromatography with electrochemical detection. Clin Chem 33: 1938-1939, 1987
17. Allman KC, Stevens MJ, Wieland DM, Hutchins GD, Wolfe ER Jr, Greene DA, Schwaiger M: Noninvasive assessment of cardiac diabetic neuropathy by carbon-11 hydroxyephedrine and positron emission tomography. J Am Coll Cardiol 22:1425-1432, 1993
18. Ziegler D: Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. Diabetes Metab Rev 10:339-383, 1994
19. Bellavere F, Balzani I, DeMasi G, Carraro M, Carenza P, Cobelli C, Thomaseth K: Power spectral analysis of heart-rate variation improves assessment of diabetic cardiac autonomic neuropathy. Diabetes 41:633-640, 1992
20. Bernardi L, Ricordi L, Lazzari P, Solda P, Calciati A, Ferrari MR, Vandea I, Finardi G, Fratino P: Impaired circadian modulation of sympathovagal activity in diabetes. Circulation 86:1443-1452, 1992
21. Waller BF, Schlant RC: Anatomy of the heart. In Hurt's the Heart, Arteries and Veins. 8th ed. Schlant RC, Alexander RW, Eds. New York, McGraw-Hill, 1994, p. 82-83
22. Pierpont GL, DeMaster EG, Cohn JN: Regional differences in adrenergic function within the left ventricle. Am J Physiol 246:H824-H829, 1984
23. Gill JS, Hunter GJ, Gane G, Camm AJ: Heterogeneity of the human myocardial sympathetic innervation: in vivo demonstration by iodine 123-labeled metaiodobenzylguanidine scintigraphy. Am Heart J 126:390-398, 1993
24. Estorch M, Carrio I, Berna L, Lopez-Pousa J, Torres G: Myocardial iodine-labeled metaiodobenzylguanidine 123 uptake relates to age. J Nucl Cardiol 2:126-132, 1995
25. Tsuchimochi S, Tamaki N, Tadamura E, Kawamoto M, Fujita T, Yonekura Y, Konishi J: Age and gender differences in normal myocardial adrenergic neuronal function evaluated by iodine-123-MIBG imaging. J Nucl Med 36:969-974, 1995
26. Mustonen J, Uusitupa M, Länsimies E, Vainio P, Laakso M, Pyörälä K: Autonomic nervous function and its relationship to cardiac performance in middle-aged diabetic patients without clinically evident cardiovascular disease. J Intern Med 232:65-72, 1992
27. Uusitupa MIJ, Mustonen JN, Airaksinen KE: Diabetic heart muscle disease. Ann Med 22:377-386, 1990
28. 123M-metaiodobenzylguanidine uptake is associated with disturbed left ventricular filling in diabetes. Am Heart J 123:804-805, 1992
29. Hartikainen J, Mäntysaari M, Kuikka J, Länsimies E, Pyörälä K: Extent of cardiac autonomic denervation in relation to angina on exercise test in patients with recent acute myocardial infarction. Am J Cardiol 74:760-763, 1994
30. Tomoda H, Yoshioka K, Siina Y, Tagawa R, Ide M, Suzuki Y: Regional sympathetic denervation detected by iodine 123 metaiodobenzylguanidine in non-Q-wave myocardial infarction and unstable angina. Am Heart J 128:452-458, 1994
31. Merlet P, Valette H, Dubois-Rande JL, Moyse D, Duboc D, Dove P, Bourguignon MH, Benvenuti C, Duval AM, Agostini D, Loisance D, Castaigne A, Syrota A: Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 33:471-477, 1992
32. 123I-metaiodobenzylguanidine (MIBG) uptake in hypertrophic cardiomyopathy Am Heart J 119:1329-1337, 1990
33. Wichter T, Hindricks G, Lerch H, Bartenstein P, Borggrefe M, Schober O, Breithardt G: Regional myocardial sympathetic dysinnervation in arrhythmogenic right ventricular cardiomyopathy. Circulation 89:667-683, 1994
34. Koistinen MJ: Prevalence of asymptomatic myocardial ischemia in diabetic subjects. Br Med J 301:92-95, 1990.
35. O'Sullivan JJ, Conroy RM, MacDonald K, McKenna TJ, Maurer BJ: Silent ischemia in diabetic men with autonomic neuropathy. Br Heart J 66:313-315, 1991